NCT01940952View on ClinicalTrials.gov

Zydena on Cognitive Function of Alzheimer's Disease Patients

PHASE3UnknownINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

August 31, 2015

Conditions
Alzheimer's Disease
Interventions
DRUG

Zydena (Udenafil) 50mg + Donepezil 5mg or 10mg

DRUG

Placebo + Donepezil 5mg or 10mg

DRUG

Zydena (Udenafil) 100mg + Donepezil 5mg or 10mg

Trial Locations (1)

135-710

Samguns Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY

lead

Samsung Medical Center

OTHER

NCT01940952 - Zydena on Cognitive Function of Alzheimer's Disease Patients | Biotech Hunter | Biotech Hunter